Concepedia

P. Scigalla

PS

51

Publications

4.8K

Citations

27

H-Index

1988

Active since

Affiliations

Roche (United States)(Current)

Humboldt-Universität zu Berlin

Heidelberg University

Charité - Universitätsmedizin Berlin

Medizinische Hochschule Hannover

P. Scigalla is an author at Roche (United States) specializing in medicine, chronic kidney disease, and nephrology.

Top concepts

Publications per year

1988–2019

51

Publications

51

Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer

Sandrine Faivre, Catherine Delbaldo, Karina Vera et al. · Journal of Clinical Oncology · 2005 · 1.1K citations · Full text

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

Walter Fiedler, Hubert Serve, Hartmut Döhner et al. · Blood · 2005 · 492 citations

Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD

Wanja M. Bernhardt, Michael S. Wiesener, P. Scigalla et al. · Journal of the American Society of Nephrology · 2010 · 338 citations · Full text

An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients.

A O’Farrell, James M. Foran, Walter Fiedler et al. · PubMed · 2003 · 311 citations

The Effect of Epoetin Beta (Recombinant Human Erythropoietin) on the Need for Transfusion in Very-Low-Birth-Weight Infants

Rolf F. Maier, Michael Obladen, P. Scigalla et al. · New England Journal of Medicine · 1994 · 271 citations · Full text

Rows per page

1–5 of 51